Biocon Biologics receives upgrade in LT issuer credit rating

From S&P Global Ratings

Biocon Biologics, subsidiary of Biocon today announced that S&P Global Ratings has upgraded the Company's long-term issuer credit rating to 'BB+' from 'BB', and revised the outlook to Stable. The rating on the senior secured notes issued by Biocon Biologics Global PLC has also been upgraded to 'BB+'.

Powered by Capital Market - Live News